Inhibiting DNMT activity has demonstrated encouraging outcomes in alleviating inflammatory skin disorders including psoriasis and AD by decreasing global DNA methylation levels and curtailing inflammatory cytokine production. Here, DNMT1 is linked to psoriasis.